Methodology of isoproterenol-tilt table testing in patients with syncope

Cardiovascular Research Group, University of Calgary, Alberta, Canada.

To assess the impact of isoproterenol, duration of tilt, symptom development and hemodynamic changes on the outcome of tilt table tests, 100 patients with syncope underwent successive 80 degrees head-up tilt for 10 min during infusions of 0, 2 and 5 micrograms/min of isoproterenol. All 15 patients with another cause of syncope had a normal test result and 66 (78%) of the 85 patients with syncope of unknown origin had a test that resulted in syncope or presyncope. Isoproterenol was required to produce syncope or presyncope in greater than 90% of positive tests and 66% to 80% of positive tests required a dose of 5 micrograms/min of isoproterenol. Without isoproterenol, symptoms did not develop until after greater than or equal to 4 min of head-up tilt. With either 2 or 5 micrograms/min of isoproterenol, the half-time of symptom onset was 0.7 to 1.9 min and the rate of symptom development did not depend on the dose of isoproterenol. During syncope, the mean heart rate, systolic blood pressure and rate-pressure product each decreased significantly from 132 +/- 21 to 67 +/- 25 beats/min, 117 +/- 19 to 60 +/- 16 mm Hg and 15.3 +/- 2.9 to 4.2 +/- 2.2 x 10(3) mm Hg/min, respectively. During presyncope, mean trough rate-pressure product (5.5 +/- 2 x 10(3) mm Hg/min) was significantly higher (p = 0.027) than during syncope.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				A. P. Vlahos, M. Tzoufi, C. S. Katsouras, T. Barka, I. Sionti, L. K. Michalis, A. Siamopoulou, and T. M. Kolettis Provocation of Neurocardiogenic Syncope During Head-up Tilt Testing in Children: Comparison Between Isoproterenol and Nitroglycerin Pediatrics, February 1, 2007; 119(2): e419 - e425. [Abstract] [Full Text] [PDF]

				R. Sheldon, S. Rose, S. Connolly, D. Ritchie, M.-L. Koshman, M. Frenneaux, and for the Syncope Symptom Study Investigators Diagnostic criteria for vasovagal syncope based on a quantitative history Eur. Heart J., February 1, 2006; 27(3): 344 - 350. [Abstract] [Full Text] [PDF]

				Béa. Brembilla-Perrot, I. Muhanna, M. Nippert, B. Popovic, D. Beurrier, P. Houriez, A. Terrier de la Chaise, O. Claudon, P. Louis, A. Abdelaal, et al. Paradoxical effect of isoprenaline infusion Europace, January 1, 2005; 7(6): 621 - 627. [Abstract] [Full Text] [PDF]

				Guidelines on Management (diagnosis and treatment) of syncope - update 2004: The Task Force on Syncope, European Society of Cardiology Europace, January 1, 2004; 6(6): 467 - 537. [Full Text] [PDF]

				R. Sheldon, S. Rose, S. Connolly, and on behalf of the POST investigators Prevention of Syncope Trial (POST): a randomized clinical trial of beta blockers in the prevention of vasovagal syncope: Rationale and study design Europace, January 1, 2003; 5(1): 71 - 75. [Abstract] [PDF]

				R. Sheldon, S. Rose, D. Ritchie, S. J. Connolly, M.-L. Koshman, M. A. Lee, M. Frenneaux, M. Fisher, and W. Murphy Historical criteria that distinguish syncope from seizures J. Am. Coll. Cardiol., July 3, 2002; 40(1): 142 - 148. [Abstract] [Full Text] [PDF]

				Task Force on Syncope, European Society of Cardiol, M Brignole, P Alboni, D Benditt, L Bergfeldt, J.J Blanc, P.E Bloch Thomsen, J.G van Dijk, A Fitzpatrick, S Hohnloser, et al. Guidelines on management (diagnosis and treatment) of syncope Eur. Heart J., August 1, 2001; 22(15): 1256 - 1306. [Abstract] [PDF]

				M. Lamarre-Cliche and J. Cusson The fainting patient: value of the head-upright tilt-table test in adult patients with orthostatic intolerance Can. Med. Assoc. J., February 1, 2001; 164(3): 372 - 376. [Abstract] [Full Text] [PDF]

				P. C. Rowe, H. Calkins, K. DeBusk, R. McKenzie, R. Anand, G. Sharma, B. A. Cuccherini, N. Soto, P. Hohman, S. Snader, et al. Fludrocortisone Acetate to Treat Neurally Mediated Hypotension in Chronic Fatigue Syndrome: A Randomized Controlled Trial JAMA, January 3, 2001; 285(1): 52 - 59. [Abstract] [Full Text] [PDF]

				A. M. Fenton, S. C. Hammill, R. F. Rea, P. A. Low, and W.-K. Shen Vasovagal Syncope Ann Intern Med, November 7, 2000; 133(9): 714 - 725. [Abstract] [Full Text] [PDF]

				R A Kenny, D O'Shea, and S W Parry The Newcastle protocols for head-up tilt table testing in the diagnosis of vasovagal syncope, carotid sinus hypersensitivity, and related disorders Heart, May 1, 2000; 83(5): 564 - 569. [Full Text]

				A Zaidi, D Benitez, P A Gaydecki, A Vohra, and A P Fitzpatrick Haemodynamic effects of increasing angle of head up tilt Heart, February 1, 2000; 83(2): 181 - 184. [Abstract] [Full Text]

				K.-C. Hung, F.-C. Lin, M.-S. Chern, H.-J. Chang, I.-C. Hsieh, and D. Wu Mechanisms and clinical significance of transient atrioventricular block during dobutamine stress echocardiography J. Am. Coll. Cardiol., October 1, 1999; 34(4): 998 - 1004. [Abstract] [Full Text] [PDF]

				W.-K. Shen, A. Jahangir, D. Beinborn, C. M. Lohse, D. O. Hodge, R. F. Rea, and S. C. Hammill Utility of a single-stage isoproterenol tilt table test in adults: A randomized comparison with passive head-up tilt J. Am. Coll. Cardiol., March 15, 1999; 33(4): 985 - 990. [Abstract] [Full Text] [PDF]

				S. Kikushima, Y. Kobayashi, H. Nakagawa, and T. Katagiri Triggering mechanism for neurally mediated syncope induced by head-up tilt test: Role of catecholamines and response to propranolol J. Am. Coll. Cardiol., February 1, 1999; 33(2): 350 - 357. [Abstract] [Full Text] [PDF]

				J. Sagrista-Sauleda, B. Romero, G. Permanyer-Miralda, A. Moya, T. Rius-Gelabert, L. Mont Girbau, and J. Soler-Soler Clinical usefulness of head-up tilt test in patients with syncope and intraventricular conduction defect Europace, January 1, 1999; 1(1): 63 - 68. [Abstract] [PDF]

				K. E. Boehm, K. T. Kip, B. P. Grubb, and D. J. Kosinski Neurocardiogenic Syncope: Response to Hormonal Therapy Pediatrics, April 1, 1997; 99(4): 623 - 623. [Full Text] [PDF]

				R. Sheldon, S. Rose, P. Flanagan, M. L. Koshman, and S. Killam Risk Factors for Syncope Recurrence After a Positive Tilt-Table<$DOWNLINK> Test in Patients With Syncope Circulation, March 1, 1996; 93(5): 973 - 981. [Abstract] [Full Text]